| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |